Skip to content

Clinical trials

Phase 3 Asthma trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 3 Country / region: India Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20054
20061
20072
20091
20103
20113
20121
20153
20172
20181
20192
20201
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated4
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Novartis Pharmaceuticals6
Boehringer Ingelheim3
Mundipharma Research Limited2
AB Science1
All India Institute of Medical Sciences1
Areteia Therapeutics1
Aurobindo Pharma Ltd1
Eli Lilly and Company1
Glenmark Pharmaceuticals Ltd. India1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma30
Diabetes Mellitus2
Churg-Strauss Syndrome1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21
Dyspnea1
Hypereosinophilic Syndrome1
Pulmonary Disease, Chronic Obstructive1
Pulmonary Eosinophilia1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.